Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1991-8-22
|
pubmed:abstractText |
Radiation detectors may allow the intraoperative localization of small cancer deposits following administration of radiolabelled tumour-associated antibodies. This technique was evaluated in 16 patients with colorectal tumours (14 cancers, one adenoma, one lipoma) with the 111In-labelled monoclonal antibody (MAb) ICR2 which recognizes the tumour-associated epithelial membrane antigen (EMA). At operation counting was carried out (3 x 20 s per site) using a hand-held radiation probe over the primary lesions and any palpable lymph nodes in the mesocolon. The tumour to normal colon (T/NC) ratio of counts recorded at operation was more than 1.5:1 in eight of the 14 patients with cancer (mean(s.d.), 1.54(0.41):1) and 0.91:1 and 1.06:1 respectively in the two patients with benign tumours. Node to normal colon ratios were higher in lymph nodes containing metastases. The uptake of radiolabelled antibody (T/NC ratio) was higher in EMA-expressing cancers than in those not expressing the target antigen (mean(s.d.), 2.45(0.65):1 versus 1.40(0.20):1, P = 0.019). An abdominal tumour model was also developed. Radioactively filled containers of 0.5-10 ml representing tumour deposits were suspended in a tank of 111In solution representing the background activity found in normal tissues. The ratio of radioactivity in the 'tumour' to that of background varied from 2:1 to 8:1. The 'tumour' was considered to be detectable if the mean counts recorded over the 'tumour' exceeded the mean of counts recorded over background by three standard deviations. At a ratio of 2:1 only 'tumours' greater than 5 ml could be detected with a sodium iodide probe and those over 10 ml could be detected with a cadmium telluride (CdTe) probe. At a ratio of 8:1, 'tumours' of 0.5 ml could be detected with either probe. At all ratios and counting periods the NaI probe was more sensitive than the CdTe.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
0007-1323
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
664-70
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2070229-Aged,
pubmed-meshheading:2070229-Aged, 80 and over,
pubmed-meshheading:2070229-Antibodies, Monoclonal,
pubmed-meshheading:2070229-Antigens, Neoplasm,
pubmed-meshheading:2070229-Colon,
pubmed-meshheading:2070229-Colonic Neoplasms,
pubmed-meshheading:2070229-Female,
pubmed-meshheading:2070229-Humans,
pubmed-meshheading:2070229-Indium Radioisotopes,
pubmed-meshheading:2070229-Intraoperative Period,
pubmed-meshheading:2070229-Lymphatic Metastasis,
pubmed-meshheading:2070229-Male,
pubmed-meshheading:2070229-Middle Aged,
pubmed-meshheading:2070229-Rectal Neoplasms,
pubmed-meshheading:2070229-Rectum
|
pubmed:year |
1991
|
pubmed:articleTitle |
Intraoperative localization of colorectal cancers using radiolabelled monoclonal antibodies.
|
pubmed:affiliation |
Department of Surgery, University College, Middlesex School of Medicine, London, UK.
|
pubmed:publicationType |
Journal Article
|